Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Engaging India: U.S. Device Industry Seeks Clear Regulations

This article was originally published in The Gray Sheet

Executive Summary

President Barack Obama’s mission to India last week, as part of a week-long Asia trip, reinforced the increasing importance placed on boosting economic ties between the two nations.

You may also be interested in...



India Device Market Requires Creative Thinking To Make A Sale

In India, cash is king. So how do you close a sale of your diagnostics equipment to a lab that operates in the massive country's large cash economy

India Device Market Requires Creative Thinking To Make A Sale

In India, cash is king. So how do you close a sale of your diagnostics equipment to a lab that operates in the massive country’s large cash economy?

India Device Market Requires Creative Thinking To Make A Sale

In India, cash is king. So how do you close a sale of your diagnostics equipment to a lab that operates in the massive country’s large cash economy?

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT029586

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel